Pathwork Diagnostics

CHANGE IN DIAGNOSIS
In a study with 111 patients, the Tissue of Origin Test was shown to impact the diagnosis:

Hornberger et al: Effect of a gene expressino-based Tissue of Origin Test on patient management for difficult-to diagnose primary cancers, poster presented at ASCO GI January 2011. San Francisco, CA
Data on file. Pathwork Diagnostics

CHANGE IN TREATMENT
The study also showed how knowing the diagnosis changed patient therapy:

Hornberger et al: Effect of a gene expressino-based Tissue of Origin Test on patient management for difficult-to-diagnose primary cancers, poster presented at ASCO GI January 2011. San Francisco, CA
Data on file. Pathwork Diagnostics

SURVIVAL OUTCOME
The study authors collected survival data on 107 of the original 111 patients, and the data show that patients who were diagnosed with the help of the Tissue of Origin Test have a median survival of 426 days:

Van de Wouw (2002), Greco, Erlander et al 2000 Greco Burris et al 2002
Greco, Rodriguiz et al 2004. Data on File. Pathwork Diagnostics

The Tissue of Origin Test is the ONLY Medicare-approved test of it's kind to provide evidence of improved patient outcomes.